Merck is developing a new anti-viral drug that would be much more profitable than Ivermectin. https://www.bloomberg.com/news/features/2021-03-25/merck-mrk-moln

Merck is developing a new anti-viral drug that would be much more profitable than Ivermectin. https://www.bloomberg.com/news/features/2021-03-25/merck-mrk-molnupiravir-pill-could-change-the-fight-against-covid https://www.bloomberg.com/news/features/2021-03-25/merck-mrk...